481 related articles for article (PubMed ID: 11406538)
41. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
42. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
43. Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene.
Nakamura M; Watanabe T; Yonekawa Y; Kleihues P; Ohgaki H
Carcinogenesis; 2001 Oct; 22(10):1715-9. PubMed ID: 11577014
[TBL] [Abstract][Full Text] [Related]
44. Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.
Kohya N; Kitajima Y; Kitahara K; Miyazaki K
Int J Mol Med; 2003 Jan; 11(1):65-9. PubMed ID: 12469220
[TBL] [Abstract][Full Text] [Related]
45. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
46. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
47. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
[TBL] [Abstract][Full Text] [Related]
49. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
50. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
51. MGMT promoter methylation and field defect in sporadic colorectal cancer.
Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
[TBL] [Abstract][Full Text] [Related]
52. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
[TBL] [Abstract][Full Text] [Related]
53. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic silencing of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in Mex- human cells.
Cairns-Smith S; Karran P
Cancer Res; 1992 Oct; 52(19):5257-63. PubMed ID: 1394130
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of O⁶-methyguanine-DNA methyltransferase by promoter hypermethylation: association of epithelial ovarian carcinogenesis in specific histological types.
Roh HJ; Suh DS; Choi KU; Yoo HJ; Joo WD; Yoon MS
J Obstet Gynaecol Res; 2011 Jul; 37(7):851-60. PubMed ID: 21450028
[TBL] [Abstract][Full Text] [Related]
56. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
57. Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene.
Qian XC; Brent TP
Cancer Res; 1997 Sep; 57(17):3672-7. PubMed ID: 9288770
[TBL] [Abstract][Full Text] [Related]
58. Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene.
Harris LC; Remack JS; Houghton PJ; Brent TP
Cancer Res; 1996 May; 56(9):2029-32. PubMed ID: 8616846
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
[TBL] [Abstract][Full Text] [Related]
60. O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.
Watanabe T; Katayama Y; Komine C; Yoshino A; Ogino A; Ohta T; Fukushima T
Int J Cancer; 2005 Feb; 113(4):581-7. PubMed ID: 15455376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
